Eurofins Scientific SEEURONEXT: ERF

Eurofins Scientific: Director/PDMR Shareholding

· Issued by Eurofins Scientific SE via Business Wire

Summary by 6ix AI

Eurofins Scientific SE, a laboratory testing company, disclosed that its CFO, Laurent Lebras, sold 2000 shares on November 2, 2026 and exercised 1000 warrants on November 4, 2026. The filing is required under European Market Abuse Regulation rules for dealings by senior managers.

Key details

  • The share sale was at EUR 89.00 per share, with an aggregated figure of EUR 178,000.00. It took place on venue XPAR (Euronext Paris) and is linked to the Eurofins stock option / free share program.
  • The 1000 warrants (rights to buy shares) were exercised at EUR 529.65 each, with an aggregated figure of EUR 529,650.00. The exercise took place off-exchange (venue XOFF) under the Eurofins warrants program.

6ix AI wrote this summary from the release below and checked it against the release.

Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Laurent Lebras

2.

Reason for the notification

a)

Position / status

CFO

b)

Initial notification / amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurofins Scientific S.E.

b)

LEI

529900JEHFM47DYY3S57

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Share

Identification code

ISIN: FR0014000MR3

Nature of the transaction

Sale of shares

Transaction is linked to the Eurofins stock option / free share / stock option program

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 89.00

2000

Aggregated information

— Aggregated volume

EUR 178,000.00

— Price

EUR 89.00

Date of the transaction

2026-11-02

Place of the transaction

XPAR

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Warrant

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Exercise of warrants under the Eurofins warrants program. Number of warrants exercised:

1000

Transaction is linked to the Eurofins warrants program

c)

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 529.65

1000

d)

Aggregated information

— Aggregated volume

EUR 529,650.00

— Price

EUR 529.65

e)

Date of the transaction

2026-11-04

g)

Place of the transaction

XOFF

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 57 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

View original source (Business Wire)Eurofins Scientific SE on 6ix

Earlier from Eurofins Scientific

All Eurofins Scientific news releases